BIO Asia–Taiwan 2023 亞洲生技大會

BIO Asia–Taiwan 2023 亞洲生技大會

講師

圓祥生技股份有限公司

 

Company Info

Name /AP Biosciences, Inc.

Address /17F., No. 3, Park St., NanGang Dist., Taipei City, Taiwan

Website /www.apbioinc.com

Presenter

Name /JENG HER

Title /CEO

Email /jher@apbioinc.com

Telephone /02-2653-2886

Fax /

Mobile /

Company Type

Biotechnology

About the Company

AP Biosciences focuses on development of innovative bispecific antibodies for immuno-oncology with its proprietary technologies, including i) the Omni-Mab antibody phage display library for targeting and activity-modulating antibody discovery, and ii) T-cube, the Target-deoendent, Teff /Ireg-modulating bisoecific antibody olatform.

Brief Description of main products or services

  1. In-house bispecific antibody pipeline
    • AP203 (T-cube bsAb). Dual-immunomodulating bispeciftc antibody for solid tumors. US IND filing expected Q3, 2022.
    • AP601 (T-cube bsAb). Targeted immno-modulating bispecific antibody blocking the adenosine pathway for PD-Ll(low)/CD73(high) tumors . In CLD/CMC stage, IND filing in 2024.
    • AP402 (T-cube bsAb). Targeted immno-modulating bispecific antibody for Herceptin-resistant breast cancer. Discovery stage, IND filing in 2024.
    • AP711. A single bispecific antibody blocking binding of ACE2 to major variants of concern of SARS-CoV-2, including wt, alpha, delta, lambda, mu and Omicron.
  2. Collaboration on development of new T-cube bispecific antibodies.

Contact Person

Name /Winnie TSENG

Email /wjtseng@apbioinc.com

Phone /0930978482